Tarsier Pharma (TARX), an Israel-based biopharma company focused on eye diseases, filed for an upsized initial public offering in the U.S. this week, expecting to raise nearly $50M in gross proceeds.
This photo taken on July 3, 2026, shows a Philippine tarsier at a nature reserve on Bohol Island in the Philippines. (Kyodo) MANILA (Kyodo) -- With their huge eyes and bodies small enough to fit in ...
A nonsteroidal eye drop formulation of dazdotuftide, TRS-01 missed its late-stage primary endpoint for controlling inflammation in uveitis, but developer Tarsier Pharma Ltd. said post-hoc analysis ...
Hosted on MSN
Tarsiers: The Tiny Primates with Giant Eyes
Use precise geolocation data. Actively scan device characteristics for identification. Store and/or access information on a device. Personalised advertising and content, advertising and content ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results